Continuous Drying of Pharmaceutical Powders Using a Twin-Screw Extruder

Manuel Kreimer, Isabella Aigner, Daniel Lepek, Johannes Khinast

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Continuous manufacturing of pharmaceuticals offers such benefits as production flexibility, reduced drug product costs, and improved product quality. Moving toward continuous manufacturing requires suitable small-scale equipment, either by development of new equipment or optimization of existing equipment. In primary manufacturing, particle properties are often altered during crystallization and have to be restored during subsequent processing. Drying a crystallized product is one of the most challenging steps, especially since attrition and agglomeration can occur. To that end, we investigated the drying behavior of a crystalline model compound with moisture levels of up to 10 wt % in a corotating twin-screw extruder. The feed mass flows on a piece of small-scale equipment used for pharmaceutical production varied between 0.5 and 2.0 kg/h. Experiments were conducted to evaluate the drying performance in various process settings. Because of a very narrow and consistent residence time distribution, extrusion drying has the potential for pharmaceutical compound drying. In our study, we successfully accomplished drying of a crystalline product with very little agglomeration and/or attrition in some process settings while preserving a crystal size similar to that of the raw material. The reduction in particle size occurred as a result of long residence times (low extruder screw speed) and a decrease in the residual moisture of the product. The aim of our work was to show the potential of extruder drying as a novel continuous manufacturing process for pharmaceuticals and to enable further process development.

Original languageEnglish
Pages (from-to)813-823
Number of pages11
JournalOrganic Process Research and Development
Volume22
Issue number7
DOIs
Publication statusPublished - 20 Jul 2018

Fingerprint

screws
Extruders
Powders
drying
Drying
Pharmaceutical Preparations
manufacturing
products
comminution
agglomeration
moisture
Moisture
Agglomeration
Crystalline materials
Residence time distribution
mass flow
Crystallization
Drug products
preserving
Extrusion

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Continuous Drying of Pharmaceutical Powders Using a Twin-Screw Extruder. / Kreimer, Manuel; Aigner, Isabella; Lepek, Daniel; Khinast, Johannes.

In: Organic Process Research and Development, Vol. 22, No. 7, 20.07.2018, p. 813-823.

Research output: Contribution to journalArticleResearchpeer-review

@article{9a464126fd54401e8f4566dc065c7677,
title = "Continuous Drying of Pharmaceutical Powders Using a Twin-Screw Extruder",
abstract = "Continuous manufacturing of pharmaceuticals offers such benefits as production flexibility, reduced drug product costs, and improved product quality. Moving toward continuous manufacturing requires suitable small-scale equipment, either by development of new equipment or optimization of existing equipment. In primary manufacturing, particle properties are often altered during crystallization and have to be restored during subsequent processing. Drying a crystallized product is one of the most challenging steps, especially since attrition and agglomeration can occur. To that end, we investigated the drying behavior of a crystalline model compound with moisture levels of up to 10 wt {\%} in a corotating twin-screw extruder. The feed mass flows on a piece of small-scale equipment used for pharmaceutical production varied between 0.5 and 2.0 kg/h. Experiments were conducted to evaluate the drying performance in various process settings. Because of a very narrow and consistent residence time distribution, extrusion drying has the potential for pharmaceutical compound drying. In our study, we successfully accomplished drying of a crystalline product with very little agglomeration and/or attrition in some process settings while preserving a crystal size similar to that of the raw material. The reduction in particle size occurred as a result of long residence times (low extruder screw speed) and a decrease in the residual moisture of the product. The aim of our work was to show the potential of extruder drying as a novel continuous manufacturing process for pharmaceuticals and to enable further process development.",
author = "Manuel Kreimer and Isabella Aigner and Daniel Lepek and Johannes Khinast",
year = "2018",
month = "7",
day = "20",
doi = "10.1021/acs.oprd.8b00087",
language = "English",
volume = "22",
pages = "813--823",
journal = "Organic process research & development",
issn = "1083-6160",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Continuous Drying of Pharmaceutical Powders Using a Twin-Screw Extruder

AU - Kreimer, Manuel

AU - Aigner, Isabella

AU - Lepek, Daniel

AU - Khinast, Johannes

PY - 2018/7/20

Y1 - 2018/7/20

N2 - Continuous manufacturing of pharmaceuticals offers such benefits as production flexibility, reduced drug product costs, and improved product quality. Moving toward continuous manufacturing requires suitable small-scale equipment, either by development of new equipment or optimization of existing equipment. In primary manufacturing, particle properties are often altered during crystallization and have to be restored during subsequent processing. Drying a crystallized product is one of the most challenging steps, especially since attrition and agglomeration can occur. To that end, we investigated the drying behavior of a crystalline model compound with moisture levels of up to 10 wt % in a corotating twin-screw extruder. The feed mass flows on a piece of small-scale equipment used for pharmaceutical production varied between 0.5 and 2.0 kg/h. Experiments were conducted to evaluate the drying performance in various process settings. Because of a very narrow and consistent residence time distribution, extrusion drying has the potential for pharmaceutical compound drying. In our study, we successfully accomplished drying of a crystalline product with very little agglomeration and/or attrition in some process settings while preserving a crystal size similar to that of the raw material. The reduction in particle size occurred as a result of long residence times (low extruder screw speed) and a decrease in the residual moisture of the product. The aim of our work was to show the potential of extruder drying as a novel continuous manufacturing process for pharmaceuticals and to enable further process development.

AB - Continuous manufacturing of pharmaceuticals offers such benefits as production flexibility, reduced drug product costs, and improved product quality. Moving toward continuous manufacturing requires suitable small-scale equipment, either by development of new equipment or optimization of existing equipment. In primary manufacturing, particle properties are often altered during crystallization and have to be restored during subsequent processing. Drying a crystallized product is one of the most challenging steps, especially since attrition and agglomeration can occur. To that end, we investigated the drying behavior of a crystalline model compound with moisture levels of up to 10 wt % in a corotating twin-screw extruder. The feed mass flows on a piece of small-scale equipment used for pharmaceutical production varied between 0.5 and 2.0 kg/h. Experiments were conducted to evaluate the drying performance in various process settings. Because of a very narrow and consistent residence time distribution, extrusion drying has the potential for pharmaceutical compound drying. In our study, we successfully accomplished drying of a crystalline product with very little agglomeration and/or attrition in some process settings while preserving a crystal size similar to that of the raw material. The reduction in particle size occurred as a result of long residence times (low extruder screw speed) and a decrease in the residual moisture of the product. The aim of our work was to show the potential of extruder drying as a novel continuous manufacturing process for pharmaceuticals and to enable further process development.

UR - http://www.scopus.com/inward/record.url?scp=85048220046&partnerID=8YFLogxK

U2 - 10.1021/acs.oprd.8b00087

DO - 10.1021/acs.oprd.8b00087

M3 - Article

VL - 22

SP - 813

EP - 823

JO - Organic process research & development

JF - Organic process research & development

SN - 1083-6160

IS - 7

ER -